About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Slc2a4
solute carrier family 2 (facilitated glucose transporter), member 4
MGI:95758
56 phenotypes from 3 alleles in 11 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Slc2a4tm1Abel/Slc2a4+
Tg(Ckmm-cre)5Khn/0
involves: 129S4/SvJae * FVB
abnormal intestinal glucose absorption J:110773
decreased muscle cell glucose uptake J:110773
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/?
involves: 129/Sv * C57BL/6
abnormal circulating glucose level J:75418
abnormal glucose tolerance J:75418
abnormal lipid homeostasis J:75418
abnormal lipid level J:75418
abnormal muscle physiology J:75418
decreased body weight J:75418
decreased fatty acid level J:75418
decreased muscle cell glucose uptake J:75418
decreased triglyceride level J:75418
hyperglycemia J:75418
increased liver glycogen level J:75418
insulin resistance J:75418
normal muscle phenotype J:75418
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Ckmm-cre)5Khn/0
involves: 129S4/SvJae * FVB
abnormal glucose homeostasis J:110773
abnormal intestinal glucose absorption J:110773
abnormal lipid homeostasis J:110773
decreased adipocyte glucose uptake J:110773
decreased muscle cell glucose uptake J:110773
increased adipocyte glucose uptake J:110773
increased circulating glucose level J:110773
increased circulating insulin level J:110773
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Fabp4-cre)1Abel/?
involves: 129S4/SvJae * FVB
abnormal glucose homeostasis J:67292
abnormal glucose tolerance J:67292
abnormal glycogen homeostasis J:67292
insulin resistance J:67292
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
involves: 129S4/SvJae * C57BL/6 * FVB
abnormal cardiovascular system physiology J:108830
altered response to myocardial infarction J:108830
decreased cardiac cell glucose uptake J:108830
decreased left ventricle systolic pressure J:108830
increased cardiac cell glucose uptake J:108830
increased glycogen level J:108830
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
involves: 129S4/SvJae * FVB
abnormal cardiovascular system physiology J:59054
abnormal glucose homeostasis J:59054
abnormal glucose tolerance J:59054
abnormal heart morphology J:59054
abnormal myocardium layer morphology J:59054
abnormal nervous system physiology J:59054
cardiac hypertrophy J:59054
decreased body weight J:59054
decreased cardiac cell glucose uptake J:59054
increased heart weight J:59054
Slc2a4tm1Jdz/Slc2a4tm1Jdz
involves: 129S1/Sv * C57BL/6
decreased adipocyte glucose uptake J:123335
decreased muscle cell glucose uptake J:123335
increased circulating glucose level J:123335
increased circulating insulin level J:123335
increased heart weight J:123335
Slc2a4tm1Jdz/Slc2a4tm1Jdz
Tg(ACTA1-cre)1Jdz/0
involves: 129S1/Sv * C57BL/6 * CBA
cardiac hypertrophy J:123335
cardiac interstitial fibrosis J:123335
decreased adipocyte glucose uptake J:123335
decreased muscle cell glucose uptake J:123335
increased adipocyte glucose uptake J:123335
increased cardiac cell glucose uptake J:123335
increased circulating glucose level J:123335
increased circulating insulin level J:123335
increased heart weight J:123335
increased muscle cell glucose uptake J:123335
thick ventricular wall J:123335
Slc2a4tm1Mch/Slc2a4+
involves: 129/Sv * C57BL/6 * SJL
impaired glucose tolerance J:97234
increased insulin secretion J:97234
pancreatic islet hyperplasia J:97234
Slc2a4tm1Mch/Slc2a4+
involves: 129/Sv * C57BL/6J * CD-1 * SJL
abnormal glucose homeostasis J:43935
abnormal glycogen homeostasis J:43935
cardiac hypertrophy J:43650
decreased muscle cell glucose uptake J:43650, J:43935
dystrophic cardiac calcinosis J:43650
heart inflammation J:43650
hepatic steatosis J:43650
normal homeostasis/metabolism phenotype J:43650, J:43935
hyperglycemia J:43650
hypertension J:43650
increased circulating insulin level J:43650, J:43935
increased fat cell size J:43650
insulin resistance J:43650, J:43935
myocardial necrosis J:43650
Slc2a4tm1Mch/Slc2a4tm1Mch
involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL
abnormal circulating glucose level J:49328
abnormal muscle physiology J:49328
cardiac hypertrophy J:49328
decreased circulating free fatty acid level J:49328
decreased circulating ketone body level J:49328
decreased gonadal fat pad weight J:49328
decreased total body fat amount J:49328
normal homeostasis/metabolism phenotype J:49328
increased circulating insulin level J:49328
increased heart weight J:49328
insulin resistance J:49328
postnatal growth retardation J:49328
premature death J:49328
Slc2a4tm1Mch/Slc2a4tm1Mch
involves: 129/Sv * C57BL/6 * C57BL/6J * SJL
abnormal skeletal muscle fiber type ratio J:75600
cardiac hypertrophy J:75600
decreased body mass index J:75600
decreased glycogen level J:75600
decreased skeletal muscle mass J:75600
impaired skeletal muscle contractility J:75600
muscle fatigue J:75600
Slc2a4tm1Mch/Slc2a4tm1Mch
involves: 129/Sv * C57BL/6J * SJL
cardiac hypertrophy J:107849
cardiac interstitial fibrosis J:107849
thick ventricular wall J:107849
Slc2a4tm1Mch/Slc2a4tm1Mch
involves: C57BL/6 * CBA
abnormal glucose homeostasis J:69914

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
04/09/2019
MGI 6.13
The Jackson Laboratory